Director, President/CEO and Board Chair · Tarsus Pharmaceuticals, Inc. · Common Stock
Side
G
Value
—
Shares
51.9K
Price
—
Executed
Dec 4, 2025
Disclosed
Dec 8, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Dec 4 executedDec 8, 2025 disclosed
TARS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Azamian Bobak R. filed this Form 4 reporting a gift of TARS on Dec 4, 2025. It became public on Dec 8, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President/CEO and Board Chair
Azamian Bobak R.cik:0001827672
Issuer
Tarsus Pharmaceuticals, Inc.cik:0001819790
Revision history · 0
No field has changed since this record was first ingested.
